MedMira Reports Second Quarter Results FY2024
HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for...
Year: 2024
FSD Pharma Announces Filing of Year-End 2023 Results
TORONTO, ON / ACCESSWIRE / April 1, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical...
GE HealthCare closes MIM Software acquisition, bolstering its portfolio and advancing its precision care strategy
With the addition of MIM Software, GE HealthCare aims to provide clinicians and healthcare systems with increasingly integrated and automated...
Spok(R) Clinches 7th Consecutive Title for Leading Satisfaction in Clinical Communications & Messaging, 2024 Black Book Annual Customer Experience Survey
NEW YORK, NY / ACCESSWIRE / April 1, 2024 / Black Book conducted surveys among thousands of healthcare professionals from...
AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in...
AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in...
Scientific Industries to Host Full Year 2023 Financial Results Investor Call on April 3, 2024
Investor Call to be held at 11:00 AM Eastern TimeBOHEMIA, NY / ACCESSWIRE / April 1, 2024 / Scientific Industries,...
CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements
Lead program, Berubicin, successfully passed pre-planned interim futility analysis milestone with recommendation from DSMB to proceed without modification in potentially...
Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results
Transitioned from Pre-Clinical to Clinical Stage company in FY 2023Phase 1/2a trial, designed to assess both healthy volunteers and patients...
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
ANN ARBOR, MI / ACCESSWIRE / April 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
Scryb Announces Private Placement
Toronto, Ontario--(Newsfile Corp. - April 1, 2024) - Scryb Inc. (CSE: SCYB) (OTC Pink: SCYRF) (FSE: EIY) ("Scryb'' or the "Company"), is...
Ottobock North America Champions Freedom of Movement Through Limb Loss & Limb Difference Awareness Month Initiatives
During Limb Loss and Limb Difference Awareness Month, Ottobock North America reaffirms its commitment to supporting the limb loss and...
My Quest Story – Pauline Chaves
NORTHAMPTON, MA / ACCESSWIRE / April 1, 2024 / Quest Diagnostics I started working for Quest Diagnostics in 2020, the...
Altior Healthcare Now Accepting Carelon and Anthem at Adolescent Residential Treatment Locations in New Hampshire and Maine
LOS ANGELES, CA / ACCESSWIRE / April 1, 2024 / Altior Healthcare, a national provider of residential mental health treatment...
Kentucky Counseling Center Acquires Flourish Psychotherapy (OH) and Rebrands It as Counseling Now
LOUISVILLE, KY / ACCESSWIRE / April 1, 2024 / Kentucky Counseling Center (KCC), a leading mental health provider in Kentucky,...
The Assistance Fund Opens New Program for Atopic Dermatitis
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Atopic DermatitisORLANDO, FL / ACCESSWIRE / April...
MentalHealth.com Appoints Abhilash Patel, Healthcare Founder and Technology Leader, to Venture Advisory Team
SAN FRANCISCO, CA / ACCESSWIRE / April 1, 2024 / Leading health technology company MentalHealth.com is pleased to announce the...
CNS Pharmaceuticals to Present at Two Investor Conferences in April
HOUSTON, TX / ACCESSWIRE / April 1, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company...
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the...
Red Light Holland Announces $750,000 Convertible Debenture Unit Offering
Toronto, Ontario--(Newsfile Corp. - April 1, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) ("Red Light Holland" or...